Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

Cultivating. Innovating. Operating: Discovering the Science of CBD

Sire Bioscience Inc’s ( CSE.SIRE , OTC: BLLXF , Forum ) business model is based on their ability to engage in the investment, production, and sale of hemp for CBD extraction. That’s the desirable scalable endgame for any cannabis company....
Dave Jackson | May 13, 2020 |

PODCAST: A CBD-focused First-to-Market Franchise Model

This podcast is part of our Cannabis Sector CEO interview series. The focus of our new StockTalk Podcasts is to help listeners and investors learn about, understand, and discover investment opportunities in the public marketplace.   Stockhouse Media's Dave Jackson was r...
Dave Jackson | September 19, 2019 |

Could DehydraTECH CBD be Worth $3 Billion a Year to Lexaria?

PCG Digital -- Hypertension, or high blood pressure as it's commonly known, affects over three million Americans every year and is a primary or contributing cause of death for 25% of them. On a global scale, hypertension kills roughly 7.6 milli on people per year . L...
Featured Submission | March 9, 2021 |

The New Cannabis & CBD Therapy for PTSD

This podcast is part of our StockTalk Cannabis Sector CEO interview series, and our mission going forward is to help listeners and investors understand more about investment opportunities in the public cannabis marketplace. There are around eight million people in the U...
Stockhouse Media | November 6, 2019 |

Buzz on the Bullboards: The Summer’s Most Talked About Sectors

The summer trading season is well underway as we celebrate a holiday here in Canada and this weekend in the US. Even on days that the markets were closed, the Bullboards on Stockhouse are wide open and busy with lively discussions on some of the biggest (and smallest) sto...
Stockhouse Editorial | June 30, 2021 |

Increased Cannabis Interest Paves Way for Cannabinoid Production

As the cannabis market has started to recover amidst the COVID-19 pandemic, investors are looking at where the market can grow. One leading candidate is cannabinoid production. THC, CBD, and other specific cannabinoids can be useful for a variety of treatments, includ...
Omri Wallach | June 9, 2020 |

Alkaline, Flavored and CBD Infused Bottled Water Maker Posts Record Growth in Q4/20

The Alkaline Water Co. shares traded 20% higher after the company reported that it posted a 51% growth in year-over-year revenue in Q4/20. Alkaline Water Company Inc. (WTER:NASDAQ; WTER:CSE) , which makes premium bottled alkaline water, flavored-infused waters, and...
Streetwise Reports | June 18, 2020 |

Vertically Integrated Hemp/CBD Player Sweet Earth Holdings Debuts on CSE

One could hardly time a better entrance to the CBD/hemp/cannabis and related space than Sweet Earth Holdings Corp.'s (SE:CSE) trading debut on May 26. Late last week, researchers from Canada's University of Lethbridge found that CBD appears to help prevent contracting C...
Streetwise Reports | May 27, 2020 |

In Conversation with Willow Biosciences – Perspectives from an Analyst & CEO

Valuation, investor perception and Willow’s ( TSX: WLLW ) market opportunity as it closes in on the production of commercial quantities of pharma grade CBD and rare cannabinoids were amongst a variety of topics covered in a recent conversation between Gr...
Featured Submission | July 14, 2020 |

California Gold: Two U.S. Hemp Revenue Streams Coming Online This Quarter

Peter Epstein of Epstein Research discusses recent developments at the company. On January 29th , California Gold Mining Inc. (CGM:CSE; CFGMF:OTCQB) announced an agreement with a North Carolina-based hemp-CBD extraction company for the sale of CBD isolate produc...
Streetwise Reports | January 30, 2020 |
1 2 3 4 5 6 7 8 9 10